Osteoarthritis of Knee Clinical Trial
Official title:
A Randomized, Double Blind, Multicentric, Placebo Controlled, Phase -II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients With Osteoarthritis of Knee
Verified date | May 2016 |
Source | Stempeutics Research Pvt Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | India: Drugs Controller General of India |
Study type | Interventional |
This trial is planed to study if allogeneic mesenchymal stem cells would be safe and beneficial in osteoarthritis of knee joint. This is a double blind study. Different doses of stem cells will be used in this study.
Status | Completed |
Enrollment | 60 |
Est. completion date | November 2014 |
Est. primary completion date | November 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 40 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Males or females in the age 40 - 70 years (both inclusive) 2. Radiographic evidence of grade 2 to 3 osteoarthritis based on the Kellgren and Lawrence radiographic criteria. 3. History of primary idiopathic osteoarthritis of the knee characterized by pain which requires intake of analgesics. 4. Self-reported difficulty in at least one of the following activities attributed to knee pain: lifting and carrying groceries, walking 400 metres, getting in and out of a chair, or going up and down stairs. 5. Patients who have been on stable medication which may be NSAIDs / Opioid or opiate analgesics, for the past three months. 6. Female patients of childbearing age must be willing to use accepted methods of contraception during the course of the study 7. Ability to provide written informed consent. Exclusion Criteria: 1. Prior or ongoing medical conditions (e.g., concomitant illness, psychiatric condition, alcoholism, drug abuse), medical history, physical findings, ECG findings, or laboratory abnormality that, in the investigator's opinion, could adversely affect the safety of the subject, makes it unlikely that the course of treatment or follow-up would be completed, or could impair the assessment of study results. 2. History of surgery, or major trauma to the study joint 3. Arthroscopy on the study joint in the previous 12 months 4. Signs of active study joint inflammation including redness, warmth, and/or, if qualifying with osteoarthritis of the knee, a large, bulging effusion of the study knee joint with the loss of normal contour of the joint at the screening visit or at the baseline examination 5. Patients who had received intraarticular steroids or hyaluronan within the last three months. 6. Infections in or around the knee. 7. Patients awaiting a replacement knee or hip joint 8. Patients with other conditions that cause pain 9. Patients with deformity of the knee joint. 10. Significantly incapacitated or disabled and would be categorized as ACR Functional Class IV (largely or wholly incapacitated), or unable to walk without assistive devices 11. Patients with other known rheumatic or inflammatory disease such as rheumatoid arthritis 12. Other pathologic lesions on x-rays of knee 13. Positive hepatitis B surface antigen, hepatitis C antibody test, Anti human immunodeficiency virus (HIV) antibody test, or RPR 14. History of Bleeding disorders 15. Known hypersensitivity to Hyaluronan products or animal sera 16. For women of child-bearing potential: positive pregnancy test or lactating [Females who are planning pregnancy within next one year should be excluded] |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
India | Department of Orthopedics, M. S. Ramaiah Memorial Hospital | Bangalore | Karnataka |
India | Department of Immunology Sanjay Gandhi Post Graduate Institute of Medical Sciences | Lucknow | Uttar Pradesh |
India | Department of Orthopedics, Kasturba Medical College | Manipal | Karnataka |
India | Seth G. S. Medical College and KEM Hospital | Mumbai | Maharashtra |
India | Jehangir Hospital | Pune | Maharashtra |
Lead Sponsor | Collaborator |
---|---|
Stempeutics Research Pvt Ltd |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number and percentage of patients with adverse events as a measure of safety and tolerability | Safety evaluation will include assessment of physical examination, periodic monitoring of vital signs (heart rate, respiratory rate, blood pressure and temperature), clinical laboratory investigations (including haematology, serum chemistry, LFT, urine-analysis) and 12-lead ECG recording. Tolerability: Adverse events monitored using information volunteered by the patients and as observed by the PI will be summarized descriptively by total number of AE(s) and compared between the study arms. |
2 years | Yes |
Secondary | Change from baseline in the WOMAC OA (Western Ontario and McMaster Universities Osteoarthritis) Index -pain subscale score | 2 years | No | |
Secondary | Change from baseline in WOMAC OA stiffness index | 2 years | No | |
Secondary | Change from baseline in WOMAC OA composite index | 2 years | No | |
Secondary | Change from baseline in ICOAP (Intermittent and Constant Osteoarthritis Pain) | 2 years | No | |
Secondary | Change from baseline in radiographic (X-ray) findings of knee | 2 years | No | |
Secondary | Change from baseline in the WORMS score (Whole-Organ Magnetic Resonance Imaging Score) of knee using MRI | 2 years | No | |
Secondary | Change from baseline in arthritis pain scores on the visual analogue scale | 2 years | No | |
Secondary | Reduction in the intake of analgesic tablets from baseline | 2 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03274713 -
Efficacy of Electro-acupuncture Versus Manual Acupuncture on Knee Osteoarthritis
|
N/A | |
Completed |
NCT04535596 -
Blood Flow Restriction Exercises and Conservative Exercises in Knee Osteoarthritis
|
N/A | |
Completed |
NCT03918291 -
Whole-body Vibration Training on Functional Performance of the Elderly With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06263517 -
Clinical Trial to Assess Efficacy, Tolerability of Rising Doses of Clodronate in Painful Knee Osteoarthritis Patients
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT01027819 -
Comparison of Outcomes in Mobile and Fixed-bearing Total Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT01186211 -
Feasibility of Outpatient Total Knee Arthroplasty
|
||
Active, not recruiting |
NCT00261066 -
Outcome Following Orthopaedic Surgery
|
||
Completed |
NCT03484910 -
Biofeedback With Cycling Exercise in OA Knee Patients
|
N/A | |
Recruiting |
NCT03884374 -
Pain Relief for OsteoArthritis Through Combined Treatment (PROACT)
|
N/A | |
Completed |
NCT03492320 -
Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
|
||
Completed |
NCT01449552 -
Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT
|
N/A | |
Completed |
NCT06254976 -
Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis
|
N/A | |
Completed |
NCT03428893 -
Mobile Technology to Support Physical Therapy Exercise
|
N/A | |
Completed |
NCT05081921 -
Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
|
Phase 1/Phase 2 | |
Completed |
NCT02850068 -
Geniculate Artery Embolization for the Treatment of Knee Pain
|
N/A | |
Active, not recruiting |
NCT03110172 -
Short-term Efficacy of Antidepressant in Patients Underwent TKA
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT02623660 -
Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery
|
N/A | |
Completed |
NCT02579174 -
Total Knee Replacement Component Alignment Using Manual Versus Custom Instrumentation
|
N/A | |
Completed |
NCT00790985 -
Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee
|
N/A | |
Recruiting |
NCT02722772 -
Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee Osteoarthritis
|
N/A |